Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
link
photo
Tags
clinical trials
drugs
life sciences
national blog main
akcea therapeutics
anylam pharmaceuticals
boston blog main
boston top stories
cannabidiol
cardiomyopathy
dravet syndrome
epidiolex
fda
fen-phen
fenfluramine
gw pharmaceuticals
inotersen
lennox-gastaut syndrome
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
tafamidis
tegsedi
transthyretin amyloidosis
zogenix
What
ago
4
×
battle
4
×
medicine
weeks
advances
approved
babies
baby
barely
began
born
boy
come
drug
far
fda
future
generation
green
joined
life
neonatal
premature
rare
sets
survival
test
thanks
unimaginable
viable
akcea
alnylam
amyloidosis
attr
available
cannabis
data
debilitating
derivative
disease
Language
Current search:
ago
×
battle
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@WIRED
6 years ago
Born at a barely viable 24 weeks, his life began as a battle for survival. His future is a test for how far neonatal medicine has come.
@WIRED
6 years ago
Born at a barely viable 24 weeks, his life began as a battle for survival. His future is a test for how far neonatal medicine has come.